BASF to Build New World-Scale Plant for Specialty Amines in Ludwigshafen
BASF is building a new world-scale plant for the production of specialty amines in Ludwigshafen. Start-up of the facility with a total annual capacity of about 12,000 metric tons is scheduled for 2015. The product range of this flexible multi-product plant comprises 15 amines for different applications. The major applications are in the construction, automotive, crop protection and pharmaceutical industries. With this new facility, BASF is expanding its global production network of amines with plants in Ludwigshafen and Schwarzheide in Germany; Antwerp, Belgium; Geismar, Louisiana; and Nanjing, China.
“With the new plant we are responding to our customers’ demand for specialty amines, particularly in Europe,” said Sanjeev Gandhi, President, BASF Intermediates division. “We have decades of experience in developing and manufacturing amines, and with the new plant we are reinforcing our global leadership position in these versatile intermediates.”
“This facility enables us to react flexibly to changes in the demand of individual products. We will also use it to produce commercial quantities of new products from our innovation pipeline,” said Dr Christoph Wegner, head of the regional business unit Amines Europe within BASF’s Intermediates division. “Being integrated into the BASF Verbund at the Ludwigshafen site allows us to scale up products from R&D to pilot scale and to commercial production in this new multi-product plant for our customers.”
BASF had announced in March that it is building another new multi-product plant for the production of specialty amines at the BASF Verbund site in Nanjing, China. The main products of this plant, which is due to start-up operations in 2015, will be dimethylaminopropylamine (DMAPA) and polyetheramine (PEA).
With about 200 different amines, BASF has the world’s most diverse portfolio of this type of chemical intermediates. Along with alkyl-, alkanol-, alkoxyalkylamines, the company offers heterocyclic and aromatic as well as specialty amines. The range is completed by an expanding portfolio of chiral amines of high optical and chemical purity. The versatile products are used mainly to manufacture process chemicals, pharmaceuticals and crop protection products, as well as cosmetic products and detergents. They also serve to produce coatings, special plastics, composites and special fibers.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance